<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">11828801</PMID>
<DateCompleted>
<Year>2002</Year>
<Month>02</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>07</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0914-5087</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>39</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2002</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cardiology</Title>
<ISOAbbreviation>J Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>[Up-regulation of inositol 1, 4, 5-trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation].</ArticleTitle>
<Pagination>
<MedlinePgn>57-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Abnormal intracellular Ca2+ homeostasis occurs in chronic atrial fibrillation(AF). The intracellular Ca2+ concentration is regulated by ryanodine and inositol 1,4,5-trisphosphate (IP3) receptors. Changes occur in ryanodine receptors in atrial tissue from patients in chronic AF. Whether AF patients have alterations in atrial IP3 receptors was investigated.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">IP3 receptor expression was analyzed in the right atrial myocardium from 13 mitral valvular disease (MVD) patients with AF (MVD/AF), 5MVD patients with normal sinus rhythm(MVD/NSR), and 8 control patients with NSR(tissue obtained during coronary artery bypass surgery). Hemodynamic and echocardiographic data were obtained preoperatively, and an immunohistochemical study was performed on the atrial tissue.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The relative expression level of IP3 receptor protein was significantly greater in MVD/AF (0.75 +/- 0.26) than in MVD/NSR (0.42 +/- 0.13, p &lt; 0.01), and both were significantly above the control value (0.14 +/- 0.08). The relative expression level of IP3 receptor mRNA was significantly greater in MVD/AF(0.028 +/- 0.008) than in control subjects (0.015 +/- 0.004, p &lt; 0.01), but MVD/AF patients did not differ from MVD/NSR (0.020 +/- 0.006) patients. The relative expression levels of IP3 receptor protein and mRNA were higher in patients with left atrial dimension &gt; or = 40 mm, pulmonary capillary wedge pressure &gt; or = 10 mmHg, and right atrial pressure &gt; or = 5 mmHg. IP3 receptors were overexpressed in the cytosol and at the nuclear envelope of atrial myocytes in MVD.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Since chronic mechanical overload of the atrial myocardium increases IP3 receptor expression, especially in patients with chronic AF, up-regulation of IP3 receptors may be important in modulating intracellular Ca2+ homeostasis and initiating and/or perpetuating AF.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yamada</LastName>
<ForeName>Jutaro</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Second Department of Internal Medicine, Yamaguchi University, School of Medicine, Minamikogushi 1-1-1, Ube, Yamaguchi 755-8505.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ohkusa</LastName>
<ForeName>Tomoko</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nao</LastName>
<ForeName>Tomoko</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ueyama</LastName>
<ForeName>Takeshi</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yano</LastName>
<ForeName>Masafumi</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kobayashi</LastName>
<ForeName>Shigeki</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hamano</LastName>
<ForeName>Kimikazu</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Esato</LastName>
<ForeName>Kensuke</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Matsuzaki</LastName>
<ForeName>Masunori</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Cardiol</MedlineTA>
<NlmUniqueID>8804703</NlmUniqueID>
<ISSNLinking>0914-5087</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015220">Calcium Channels</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C506926">ITPR1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053496">Inositol 1,4,5-Trisphosphate Receptors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015220">Calcium Channels</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000096">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006325">Heart Atria</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D053496">Inositol 1,4,5-Trisphosphate Receptors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018160">Receptors, Cytoplasmic and Nuclear</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000096">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2002</Year>
<Month>2</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2002</Year>
<Month>2</Month>
<Day>16</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2002</Year>
<Month>2</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11828801</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>